相关实验视频
Updated: Sep 9, 2025

05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
347
与伴随肥胖症的严重抑郁症的临床治疗
Nils Opel1, Ruth Hanssen2, Lavinia A Steinmann3
1Department of Psychiatry and Neuroscience, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, Berlin, Germany; German Center for Mental Health (DZPG), Partner Site Berlin-Potsdam, Germany.
The lancet. Psychiatry
|August 31, 2025
概括
抑郁症和肥胖症有着复杂的关系, 形成一个影响治疗的循环. 这一综述提供了一个综合框架来管理伴随性抑郁症和肥胖症.
科学领域:
- 精神病学
- 内分泌学
- 公共卫生
背景情况:
- 肥胖是主要抑郁症 (MDD) 的常见并发症,对其预后有重大影响.
- 患MDD和肥胖之间的双向关系为患者和临床医生构成了具有挑战性的反循环.
- 不有效的管理源于跨学科合作的碎片化和知识差距.
研究的目的:
- 综合当前关于治疗并发性严重抑郁症和肥胖症的证据.
- 提出一个风险分层和监测框架,整合心理和代谢因素.
- 为此复杂的患者群体提供临床决策指导.
主要方法:
- 这篇叙述综合了现有关于主要抑郁症和肥胖症的研究.
- 检查药物,心理治疗和生活方式干预的证据.
- 提出了一个综合风险评估和监测的框架.
主要成果:
- 目前的证据支持针对抑郁症状和体重控制的干预措施.
- 包括运动和饮食改变在内的生活方式策略至关重要.
- 药物治疗和心理治疗可以缓解抑郁症症状并帮助控制体重.
结论:
- 综合,跨学科的方法对于有效治疗并发性严重抑郁症和肥胖症至关重要.
- 结合心理和代谢监测可以改善临床决策.
- 优化护理需要为医疗保健提供者提供实际指导, 以改善患者的治疗结果.
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
340
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
340
Depressive Disorders: MDD and Dysthymia
208
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
208
Depression: Overview
331
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
331
Binge Eating Disorders
168
Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...
168
Antidepressant Drugs: Overview
741
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
741
Diabetes: Management and Pharmacotherapy
354
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
354

